<--- Back to Details
First PageDocument Content
Ipilimumab / Vemurafenib / Immunotherapy / Skin cancer / BRAF / Targeted therapy / Cancer / Chemotherapy / Uveal melanoma / Medicine / Cancer treatments / Melanoma
Date: 2014-03-20 21:37:51
Ipilimumab
Vemurafenib
Immunotherapy
Skin cancer
BRAF
Targeted therapy
Cancer
Chemotherapy
Uveal melanoma
Medicine
Cancer treatments
Melanoma

NEW THERAPIES GIVING HOPE FOR PATIENTS WITH ADVANCED MELANOMA Cutting-edge treatments represent recent surge in research aimed at battling melanoma Denver March 21, 2014

Add to Reading List

Source URL: www.pwrnewmedia.com

Download Document from Source Website

File Size: 214,85 KB

Share Document on Facebook

Similar Documents

03_2018_ΟΔΗΓΙΕΣ BRAF_ΜΕΛΑΝΩΜΑ_CLEAN

03_2018_ΟΔΗΓΙΕΣ BRAF_ΜΕΛΑΝΩΜΑ_CLEAN

DocID: 1tOTO - View Document

Collection BRAF : wiki ballons n° 1.0  f6agv @ free.fr - Alain Verbrugge CONDITION DE DECOLLAGE D’UN BALLON SOLAIRE  photo : f6agv

Collection BRAF : wiki ballons n° 1.0 f6agv @ free.fr - Alain Verbrugge CONDITION DE DECOLLAGE D’UN BALLON SOLAIRE photo : f6agv

DocID: 1sWxr - View Document

Atypical Protein Kinases (aPKs) Supplemental Online Material for Manning et al (Science 298:Atypical protein kinases lack sequence similarity to the ePK domain HMM profile, but have been shown experimentally t

Atypical Protein Kinases (aPKs) Supplemental Online Material for Manning et al (Science 298:Atypical protein kinases lack sequence similarity to the ePK domain HMM profile, but have been shown experimentally t

DocID: 1qVny - View Document

Letter pubs.acs.org/acsmedchemlett Structural Analysis of the Binding of Type I, I1/2, and II Inhibitors to Eph Tyrosine Kinases Jing Dong,*,† Hongtao Zhao,† Ting Zhou,† Dimitrios Spiliotopoulos,† Chitra Rajendra

Letter pubs.acs.org/acsmedchemlett Structural Analysis of the Binding of Type I, I1/2, and II Inhibitors to Eph Tyrosine Kinases Jing Dong,*,† Hongtao Zhao,† Ting Zhou,† Dimitrios Spiliotopoulos,† Chitra Rajendra

DocID: 1pvTL - View Document

Signature® BRAF Mutations Kit The Signature® BRAF Mutations Kit is a qualitative in vitro diagnostic device to identify specific BRAF mutations in genomic DNA extracted from formalin-fixed paraffin-embedded (FFPE) colo

Signature® BRAF Mutations Kit The Signature® BRAF Mutations Kit is a qualitative in vitro diagnostic device to identify specific BRAF mutations in genomic DNA extracted from formalin-fixed paraffin-embedded (FFPE) colo

DocID: 1lWFv - View Document